Digital pathology and lipid droplet size as a key determinant of discrepancies between histology and MRI gradings in steatotic liver disease - Report - MDSpire

Digital pathology and lipid droplet size as a key determinant of discrepancies between histology and MRI gradings in steatotic liver disease

  • By

  • David Marti-Aguado

  • Clara Alfaro-Cervello

  • Matías Fernández-Patón

  • Amadeo Ten-Esteve

  • Leonor Cerdá-Alberich

  • Ana Crespo

  • Irene Navarrete-Pérez

  • María Pilar Ballester

  • Alexandre Perez-Girbes

  • Cristina Montón

  • Judith Pérez-Rojas

  • Víctor Puglia

  • Antonio Ferrández

  • Victoria Aguilera

  • Desamparados Escudero-García

  • Salvador Benlloch

  • Ana Jimenez-Pastor

  • Ángel Alberich-Bayarri

  • Claude B. Sirlin

  • Luis Marti-Bonmati

  • August 8, 2025

  • 0 min

Share

Digital Pathology and Lipid Droplet Size Explain Histology vs MRI Differences in Liver Steatosis

Overview

This study investigated discrepancies between histological and MRI-proton density fat fraction (PDFF) assessments of hepatic steatosis by analyzing lipid droplet (LD) size distribution using digital image analysis (DIA). Findings indicate that small and tiny LDs, often overlooked in histology, contribute significantly to steatosis burden and explain differences in grading compared to MRI-PDFF.

Background

Steatotic liver disease is a prevalent global health issue with histological evaluation as the current standard for assessing hepatic steatosis. Conventional microscopy focuses on large lipid droplets displacing hepatocyte nuclei, often missing small and tiny LDs. MRI-PDFF offers a non-invasive, sensitive method for quantifying liver fat but shows grading discrepancies compared to histology. Digital pathology and DIA provide objective morphometric analysis of LD size, potentially clarifying these differences.

Data Highlights

Steatosis GradeHistology CriteriaMRI-PDFF Criteria
S0<5% hepatocytes with large LDs<5.75% PDFF
S15–33% hepatocytes with large LDs≥5.75% PDFF
S234–66% hepatocytes with large LDs≥15.5% PDFF
S3>66% hepatocytes with large LDs≥21.35% PDFF

Key Findings

  • Histological grading focuses on large LDs displacing the nucleus, excluding tiny and small LDs.
  • Digital image analysis quantified LD size distribution, including tiny (<1 μm²) and small droplets.
  • MRI-PDFF detects total liver fat content, including small and tiny LDs, leading to higher sensitivity.
  • Discrepancies between histology and MRI-PDFF grades are partly explained by the presence of small and tiny LDs overlooked in histology.
  • Digital pathology offers a more granular and objective steatosis quantification, supporting MRI-PDFF validation.

Clinical Implications

Clinicians should recognize that histological assessment may underestimate liver fat content due to exclusion of small and tiny lipid droplets. MRI-PDFF provides a more comprehensive and sensitive evaluation of steatosis, useful for monitoring treatment response. Incorporating digital pathology techniques can enhance biopsy analysis accuracy and reconcile differences with imaging findings.

Conclusion

The size distribution of lipid droplets, particularly the overlooked small and tiny droplets, accounts for differences between histological and MRI-PDFF steatosis grading. Digital pathology combined with MRI-PDFF offers a robust approach for accurate liver fat quantification in chronic liver disease.

References

  1. Banff Liver Working Group -- Recommendations on microvesicular steatosis
  2. NASH-CRN and SAF scoring systems -- Histological steatosis grading
  3. MRI-PDFF validation studies -- Non-invasive liver fat quantification
  4. Digital pathology in liver transplantation -- Quantifying lipid droplet content

Original Source(s)

Related Content